Quest Diagnostics
DGX
#1081
Rank
ยฃ15.44 B
Marketcap
ยฃ138.11
Share price
0.86%
Change (1 day)
11.05%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Quest Diagnostics (DGX) - Total debt

Total debt on the balance sheet as of September 2025 : ยฃ4.78 Billion

According to Quest Diagnostics 's latest financial reports the company's total debt is ยฃ4.78 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Quest Diagnostics - Total debt on balance sheet (from 1997 to 2025)

Total debt by year

Year Total debt Change
2024-12-31ยฃ5.64 B30.86%
2023-12-31ยฃ4.31 B10.75%
2022-12-31ยฃ3.89 B10.2%
2021-12-31ยฃ3.53 B0.24%
2020-12-31ยฃ3.52 B-14.6%
2019-12-31ยฃ4.13 B31.36%
2018-12-31ยฃ3.14 B10.23%
2017-12-31ยฃ2.85 B-6.49%
2016-12-31ยฃ3.05 B23.82%
2015-12-31ยฃ2.46 B2.51%
2014-12-31ยฃ2.40 B18.98%
2013-12-31ยฃ2.01 B-2.95%
2012-12-31ยฃ2.08 B-19.63%
2011-12-31ยฃ2.58 B33.69%
2010-12-31ยฃ1.93 B0.87%
2009-12-31ยฃ1.92 B-8.72%
2008-12-31ยฃ2.10 B18.03%
2007-12-31ยฃ1.78 B124.37%
2006-12-31ยฃ0.79 B-13.97%
2005-12-31ยฃ0.92 B61.32%
2004-12-31ยฃ0.57 B-7.15%
2003-12-31ยฃ0.61 B20.16%
2002-12-31ยฃ0.51 B-9.49%
2001-12-31ยฃ0.56 B-17.56%
2000-12-31ยฃ0.68 B-8.71%
1999-12-31ยฃ0.75 B169.42%
1998-12-31ยฃ0.27 B-10.8%
1997-12-31ยฃ0.31 B0.15%
1996-12-31ยฃ0.31 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
LabCorp
LH
ยฃ4.89 B 2.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
ยฃ0.87 M-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
ยฃ0.30 B-93.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
ยฃ2.25 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
ยฃ1.59 B-66.67%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands